UPL to Launch Rice Insecticide Flupyrimin

By Krishi Jagran|7 February 2022

Agrochemical major UPL is hoping for a rebound in the current rabi season after a muted performance in Kharif, according to Krishi Jagran. The company is introducing new rice and sugarcane technologies that it believes will help drive growth.

“Rabi should do well in India. It is our most important quarter globally. We should be able to keep growing,” said Jai Shroff, Global CEO of UPL.

Unfavorable weather conditions during the Kharif season reduced demand for key target crops, resulting in flat revenue growth in the Indian market. UPL’s Indian operations generated 907 crore in revenue in the December quarter, compared to 906 crore in the same period last year.

“Draft in Madhya Pradesh and cyclonic weather in Andhra Pradesh impacted the Indian market. We are confident that the Indian market will grow further this year,” Shroff said.

UPL recently received approval to market Flupyrimin, a rice insecticide, in India. Flupyrimin was licensed by UPL from Meiji in Japan. “That technology will be available this quarter.” “We anticipate strong growth as a result of this,” Shroff said.